SEC Form 4 · accession 0001209191-19-010053
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fondation Rennes
10% Owner
Period of report
Dec 21, 2018
Accepted (ET)
Feb 14, 2019 · 2:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 21, 2018 | P | 4,200 | $6.24 | A | 3,590,182 | D | |
| Common Stock | Dec 27, 2018 | P | 2,200 | $4.98 | A | 3,592,382 | D | |
| Common Stock | Jan 2, 2019 | P | 900 | $5.15 | A | 3,593,282 | D | |
| Common Stock | Feb 6, 2019 | P | 35,000 | $8.93 | A | 3,628,282 | D | |
| Common Stock | Feb 6, 2019 | P | 30,000 | $9.49 | A | 3,658,282 | D | |
| Common Stock | Feb 7, 2019 | P | 40,000 | $10.00 | A | 3,698,282 | D |
Table II — derivative securities
No Table II lines on this filing.